Loading...
Bioceres saw a 40% year-over-year decline in Q4 revenue due to softer demand in Argentina and a shift in its seed business model. The company posted a net loss of $48 million and negative adjusted EBITDA, reflecting transitory impacts and margin pressures.
Management expects normalization of market conditions and has taken steps to reduce costs, align capital allocation, and improve working capital efficiency.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance